Therapeutics Against Infectious Diseases

Support a Phase I Clinical Trial Unit for Therapeutics Against Infectious Diseases in order to move promising therapeutic candidates into the clinical pipeline. Such studies are often on the critical path for product development. The National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), of the Department of Health and Human Services (DHHS) supports research related to the basic understanding of microbiology and immunology leading to the development of vaccines, therapeutics, and medical diagnostics for the prevention, treatment, and diagnosis of infectious and immune-mediated diseases. The NIAID Division of Microbiology and Infectious Diseases (DMID) supports extramural research to control and prevent diseases caused by virtually all infectious agents other than human immunodeficiency virus (HIV).